2022 Data Briefings
This data briefing underscores the need to improve the overall time to diagnosis allowing more women to be diagnosed when they have a better chance of starting and tolerating treatment.
This data briefing underscores the need for urgency in declaring ovarian cancer a global priority so the increasing burden and challenges of providing the best possible care are recognized at national, regional, and local levels.
Access to Treatments
Ovarian Cancer Treatment Mapping
Every Woman Study™ 2018
Guided by an international expert advisory panel, the World Ovarian Cancer Coalition undertook the Every Woman Study™ in 2018. The Study included the largest-ever global survey of women with the disease. The objective was simple: to address the evidence gap and identify a way forward to ensure the best chance of survival and the best quality of life for women with ovarian cancer.
Peer reviewed and published in the International Journal of Gynecologic Cancer, the Study included qualitative research with women in low- and middle-income countries and the 2018 World Ovarian Cancer Coalition Atlas – a literature review of incidence, mortality, survival, and trends around the world.
The Study showed what was already suspected – that there are major differences around the world in terms of best practices and local challenges in addressing ovarian cancer. No single region or country has all the answers, and all could benefit if best practices were shared and the variations were addressed. The results highlighted a number of critical areas of focus that form the heart of the Global Ovarian Cancer Charter and the six Global Goals.
This report presents information gathered during qualitative interviews with a range of clinicians in different locations around the world early in 2018, and from an online survey conducted between May 8th and June 23rd 2018. There were 28 respondents.
Full Results Report
This report summarises the findings of the quantitative work carried out amongst women who were diagnosed with ovarian cancer since the beginning of 2013. It provides up to date information that can be presented to governments and healthcare providers about the national situation in the global context, and offers opportunities to drive forward progress.
2020 Charter Documents
We are grateful to our volunteers who have helped us with the following translations. If you don’t see a language listed below and would like to help us create that translation, please do get in touch by emailing our Director of Communications and Marketing.
The Global Ovarian Cancer Charter is intended as a living document that will evolve over time. The document here represents a particular moment in time and will be updated as the Coalition and our partners move through implementation.
Supporting the Global Priority goal, the 2020 World Ovarian Cancer Atlas was launched in October 2020. The incidence of ovarian cancer is set to rise by 47% by the year 2040, with the burden most felt by those in low- and middle-income countries. This comprehensive literature view examines this in detail and explains why making ovarian cancer a global priority is urgent.
Global Priority Event Report
This report summarises the virtual meeting, ‘Making Ovarian Cancer a Global Priority’, which took place on 22nd October 2020 as part of the Global Ovarian Cancer Charter Summit Series. A recording of the meeting is available [here].
The purpose of the meeting was to highlight key challenges and opportunities for improving survival and quality of life for women with ovarian cancer and to explore in particular the gap between care for women in high resource settings compared to those living in low- and middle-resource settings.
Better Data Event Report
This report summarises the virtual meeting, Ovarian Cancer: Better Data, Better Outcomes, which took place on 18th November 2020 as part of the Global Ovarian Cancer Charter Summit Series. Recordings of the individual elements of the meeting are available [here].
The purpose of the meeting was to highlight key challenges and opportunities for improving ovarian cancer data collection, with a view to improving cancer control and planning, and improving outcomes.